Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

83
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
83
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

986
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
986
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

609
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
609
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

Journal of medicinal chemistry·2026
Same author

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
Same author

Molecular Dynamics Workflows to Compute Large-Scale Sets of Absolute Binding Free Energies Aiding Drug Candidate and Binding Pose Selection.

Journal of chemical theory and computation·2026
Same author

Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors.

Biochemical pharmacology·2026
Same author

Synthesis of Hydrazidoureidobenzensulfonamides Incorporating a Nicotinoyl Tail and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

FAME3R: an efficient, practical and reliable open-source tool for predicting phase 1 and phase 2 sites of metabolism.

Journal of cheminformatics·2026

Related Experiment Video

Updated: Jun 12, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K

Approaching Pharmacological Space: Events and Components.

Giulio Vistoli1, Carmine Talarico2, Serena Vittorio3

  • 1Dipartimento di Scienze Farmaceutiche, Università Degli Studi di Milano, Milan, Italy. giulio.vistoli@unimi.it.

Methods in Molecular Biology (Clifton, N.J.)
|September 23, 2024
PubMed
Summary

The pharmacological space considers all molecular states for improved drug discovery. This approach enhances virtual screening and toxicity prediction by analyzing dynamic ligand-target interactions.

Keywords:
Binding spaceMolecular dockingMolecular flexibilityPharmacological spaceSars-CoV-2 M-ProTRPM8Toxicity predictionVirtual screeninghERG

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.8K
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.4K

Related Experiment Videos

Last Updated: Jun 12, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.8K
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.4K

Area of Science:

  • Computational chemistry
  • Molecular modeling
  • Drug discovery

Background:

  • The pharmacological space encompasses dynamic molecular events influencing bioactivity, metabolism, and toxicity.
  • It accounts for structural flexibility, property variability, and mutual adaptability in molecular recognition.
  • Traditional methods often focus on the most probable molecular state, neglecting dynamic behaviors.

Purpose of the Study:

  • To introduce and validate the concept of pharmacological space for computational drug discovery.
  • To demonstrate the application of pharmacological space parameters in enhancing virtual screening and toxicity prediction.
  • To present a computational workflow combining docking and rescoring for descriptor enrichment.

Main Methods:

  • Calculation of state-dependent ligand- and structure-based descriptors across all monitored molecular states.
  • Evaluation of descriptor spaces using dynamic parameters like mean and range values.
  • Integration of docking simulations and rescoring analyses, followed by consensus modeling using the EFO approach.

Main Results:

  • Inclusion of pharmacological space parameters significantly improved performance in virtual screening and toxicity prediction.
  • Combining different binding modes and target structures yielded beneficial effects.
  • The proposed computational workflow demonstrated general applicability across various targets and docking engines.

Conclusions:

  • The pharmacological space offers a more comprehensive approach to understanding ligand-target interactions.
  • This methodology enhances the accuracy and performance of structure-based virtual screening and toxicity prediction.
  • The developed computational workflow provides a robust and broadly applicable tool for drug discovery.